Innospec Stock Performance
| IOSP Stock | USD 98.70 0.47 0.47% |
The company retains a Market Volatility (i.e., Beta) of 0.8, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Innospec's returns are expected to increase less than the market. However, during the bear market, the loss of holding Innospec is expected to be smaller as well. At this point, Innospec has a negative expected return of -0.16%. Please make sure to check out Innospec's information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if Innospec performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Innospec has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors. ...more
Actual Historical Performance (%)
One Day Return (0.01) | Five Day Return 0.85 | Year To Date Return (7.87) | Ten Year Return 122.3 | All Time Return 492.06 |
Forward Dividend Yield 0.0161 | Payout Ratio | Last Split Factor 2:1 | Forward Dividend Rate 1.58 | Dividend Date 2024-11-26 |
1 | Burney Co. Acquires New Stake in Innospec Inc. - MarketBeat | 01/16/2025 |
2 | Disposition of 1318 shares by Patrick Williams of Innospec at 123.96 subject to Rule 16b-3 | 02/14/2025 |
3 | Innospec Non-GAAP EPS of 1.41 beats by 0.05, revenue of 466.8M beats by 19.37M | 02/18/2025 |
4 | Disposition of 652 shares by Blackmore Milton C of Innospec at 103.3012 subject to Rule 16b-3 | 02/21/2025 |
5 | Disposition of 598 shares by Corbin Barnes of Innospec at 99.68 subject to Rule 16b-3 | 02/24/2025 |
6 | Director Milton Blackmore Sells 652 Shares of Innospec Inc | 02/25/2025 |
7 | Innospec and UNESCO IESALC Sign Partnership to Increase Indigenous Participation in Stem Education and Initiatives in Brazil | 02/26/2025 |
8 | Innospec Inc. SVP Sells 278,083.60 in Stock | 02/28/2025 |
9 | Disposition of 4275 shares by Ian Cleminson of Innospec at 100.9775 subject to Rule 16b-3 | 03/03/2025 |
10 | Innospecs CFO Makes a Major Stock Move - TipRanks | 03/04/2025 |
11 | SVB Wealth LLC Takes Position in Innospec Inc. | 03/06/2025 |
12 | Innospec Approves New 50MM Share Repurchase Program | 03/10/2025 |
13 | Chlorinated Fatty Acid Methyl Ester Market to Reach USD .7 Billion by 2032, CAGR 6.05 Innospec Inc, Gulbrandsen, Johnson Matthey, Trecora Resources | 03/12/2025 |
14 | Some Investors May Be Worried About Innospecs Returns On Capital | 03/13/2025 |
| Begin Period Cash Flow | 203.7 M |
Innospec |
Innospec Relative Risk vs. Return Landscape
If you would invest 10,917 in Innospec on December 19, 2024 and sell it today you would lose (1,047) from holding Innospec or give up 9.59% of portfolio value over 90 days. Innospec is currently does not generate positive expected returns and assumes 1.7375% risk (volatility on return distribution) over the 90 days horizon. In different words, 15% of stocks are less volatile than Innospec, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Innospec Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Innospec's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Innospec, and traders can use it to determine the average amount a Innospec's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0896
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IOSP |
Estimated Market Risk
| 1.74 actual daily | 15 85% of assets are more volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Innospec is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innospec by adding Innospec to a well-diversified portfolio.
Innospec Fundamentals Growth
Innospec Stock prices reflect investors' perceptions of the future prospects and financial health of Innospec, and Innospec fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Innospec Stock performance.
| Return On Equity | 0.0301 | ||||
| Return On Asset | 0.0119 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | (0.24) % | ||||
| Current Valuation | 2.2 B | ||||
| Shares Outstanding | 24.96 M | ||||
| Price To Earning | 96.38 X | ||||
| Price To Book | 2.02 X | ||||
| Price To Sales | 1.34 X | ||||
| Revenue | 1.85 B | ||||
| Gross Profit | 542.9 M | ||||
| EBITDA | 224.6 M | ||||
| Net Income | 35.6 M | ||||
| Cash And Equivalents | 71.4 M | ||||
| Cash Per Share | 2.88 X | ||||
| Total Debt | 44.9 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 2.16 X | ||||
| Book Value Per Share | 48.53 X | ||||
| Cash Flow From Operations | 184.5 M | ||||
| Earnings Per Share | 1.42 X | ||||
| Market Capitalization | 2.48 B | ||||
| Total Asset | 1.73 B | ||||
| Retained Earnings | 1.02 B | ||||
| Working Capital | 585.2 M | ||||
| Current Asset | 458.7 M | ||||
| Current Liabilities | 206.1 M | ||||
About Innospec Performance
Assessing Innospec's fundamental ratios provides investors with valuable insights into Innospec's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Innospec is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 84.35 | 106.68 | |
| Return On Tangible Assets | 0.03 | 0.03 | |
| Return On Capital Employed | 0.13 | 0.10 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.03 | 0.03 |
Things to note about Innospec performance evaluation
Checking the ongoing alerts about Innospec for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Innospec help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Innospec generated a negative expected return over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Some Investors May Be Worried About Innospecs Returns On Capital |
- Analyzing Innospec's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Innospec's stock is overvalued or undervalued compared to its peers.
- Examining Innospec's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Innospec's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Innospec's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Innospec's stock. These opinions can provide insight into Innospec's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Innospec Stock Analysis
When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.